News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Fidelity Biosciences Injects $65M, Takes Over EnVivo Pharmaceuticals, Inc.
October 31, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Dow Jones - Oct 31, 2008 - Fidelity Biosciences has injected $65 million into EnVivo Pharmaceuticals Inc. and bought out all other venture investors in the neurological-drug developer.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
MORE ON THIS TOPIC
Job Trends
The wait continues: pressure to operate lean among factors behind slow job market
June 11, 2026
·
4 min read
·
Angela Gabriel
IPO
Update: Parabilis raises industry-record $670M IPO
June 10, 2026
·
2 min read
·
Gabrielle Masson
Alzheimer’s disease
Lilly bets up to $1B+ with AlzeCure in search for next Alzheimer’s act
June 10, 2026
·
2 min read
·
Tristan Manalac
Podcast
Lilly tees off with Novo at ADA, GSK’s $10.6B deal, FDA reform continues in Makary’s absence
June 10, 2026
·
2 min read
·
Jef Akst
